Cargando…
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Cancer is the second leading cause of death in the United States with 1.7 million new cases estimated to be diagnosed in 2016. This disease remains a formidable clinical challenge and represents a substantial financial burden to the US health care system. Therefore, research and development of novel...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054289/ https://www.ncbi.nlm.nih.gov/pubmed/27774065 http://dx.doi.org/10.3389/fphar.2016.00361 |